Use of a phycoerythrin-conjugated anti-glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry

Citation
P. Lloyd-evans et al., Use of a phycoerythrin-conjugated anti-glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry, TRANSFUS M, 9(2), 1999, pp. 155-160
Citations number
14
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
TRANSFUSION MEDICINE
ISSN journal
09587578 → ACNP
Volume
9
Issue
2
Year of publication
1999
Pages
155 - 160
Database
ISI
SICI code
0958-7578(199906)9:2<155:UOAPAA>2.0.ZU;2-2
Abstract
The use of flow cytometry for quantifying fetomaternal haemorrhage is incre asing, and has been shown to be more accurate than the Kleihauer-Betke test for evaluating larger bleeds of over 4 mL in volume. Red cells are stained with fluorescently labelled monoclonal anti-D. Cells for analysis are norm ally gated manually on the basis of forward and side scatter. We investigat ed whether the use of an antiglycophorin A monoclonal antibody conjugate (r ed cell specific) in a dual labelling technique would improve the gating of RBC and FMH quantification. Mixes of adult rr and cord R(1)r RBC were prepared to simulate 1, 0.5, 0.25 , 0.12 and 0.06% fetal bleeds. Phycoerythrin-conjugated BRIC 256 (mouse mon oclonal antiglycophorin A) was used to label all RBC, and FITC-BRAD-3 monoc lonal anti-D was used to determine the proportion of D-positive cells. Resu lts from the dual labelling experiments were compared to those from single labelling of the same mixtures with FITC-BRAD-3 alone, using gated and unga ted data. The results showed that single labelling with manual gating gave falsely low FMH estimates. We conclude that use of a fluorescently labelled antiglycophorin A antibody improves the accuracy of the FMH measurement by flow cytometry, as manual subjective gating of RBC excludes a higher proportion of fetal than of adul t RBC.